Bowhead Specialty Holdings (BOW) Announces 4M Share Secondary Offering

Bowhead Specialty Holdings Inc. (NYSE: BOW) (the “Company”, “Bowhead Specialty”, “we” or “our”) announced the launch of a proposed underwritten secondary public offering of 4,000,000 shares of its common stock by certain of its stockholders (the “Selling Stockholders”). In connection with the proposed offering, certain of the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of the Company’s common stock. The proposed offering is subject to market and other conditions.

The Company is not selling any shares of its common stock in the proposed offering and will not receive any of the proceeds from the sale.

J.P. Morgan, Morgan Stanley and Keefe, Bruyette & Woods, A Stifel Company are acting as joint lead bookrunning managers for the proposed offering.

The proposed offering is being made only by means of a prospectus. Copies of the preliminary prospectus relating to the proposed offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at [email protected] and [email protected]; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; or Keefe, Bruyette & Woods, Inc., Attention: Capital Markets, 787 Seventh Avenue, 4th Floor, New York, NY 10019, or by email at [email protected], or by telephone at (800) 966 1559.

A registration statement on Form S-1, including a preliminary prospectus, relating to these securities has been filed with the Securities and Exchange Commission (the “SEC”) but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sale of securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Viking Therapeutics plans $400M raise via stock and note offerings
• Saratoga Investment prices $20.08M in additional 8% notes due 2031
• Valion Bio names board member Dean Zikria as interim CEO